Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GYRE

Gyre Therapeutics Inc

Dec 01 • 04:00PM ET

23.40

Dollar change -0.12
Percentage change -0.51	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-17.57	Insider Own	83.95%	Shs Outstand	76.58M	Perf Week	20.56%
Market Cap	1.79B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	12.29M	Perf Month	272.02%
Income	-44.24M	PEG	-	EPS next Q	-	Inst Own	0.18%	Short Float / Ratio	0.40% / 0.91	Perf Quarter	243.08%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	-1.54%	Short Interest	0.05M	Perf Half Y	575.32%
Book/sh	-11.77	P/B	-	EPS next Y	-	ROA	-215.90%	Target Price	45.00	Perf Year	351.94%
Cash/sh	0.03	P/C	803.57	EPS next 5Y	-	ROE	-269.01%	52W Range	2.83 - 27.39	Perf YTD	377.73%
Dividend	-	P/FCF	-	EPS past 5Y	48.84%	ROI	-1257.95%	52W High	-14.56%	Beta	2.03
Dividend %	-	Quick Ratio	2.88	Sales past 5Y	-70.71%	Gross Margin	-29.47%	52W Low	726.71%	ATR	2.50
Employees	7	Current Ratio	2.88	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	74.66	Volatility	19.25% 16.24%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	73.25%	Profit Margin	-	Rel Volume	1.80	Prev Close	23.52
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	53.49K	Price	23.40
Recom	2.00	SMA20	72.59%	SMA50	144.66%	SMA200	297.27%	Volume	96,236	Change	-0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-29-21	Resumed	Stephens	Overweight	$18 → $19
Feb-10-21	Initiated	Piper Sandler	Overweight	$15
May-21-20	Initiated	Raymond James	Outperform	$20
Jan-04-19	Initiated	Oppenheimer	Outperform	$24
Feb-12-18	Reiterated	B. Riley FBR, Inc.	Buy	$19 → $49
Feb-09-18	Reiterated	Chardan Capital Markets	Buy	$37.50 → $75
Feb-09-18	Reiterated	Chardan Capital Markets	Buy	$10 → $75
Dec-08-17	Initiated	B. Riley FBR, Inc.	Buy	$19
Jun-12-17	Initiated	Chardan Capital Markets	Buy	$10
Jun-06-17	Initiated	Ladenburg Thalmann	Buy	$11
Jun-30-16	Initiated	Rodman & Renshaw	Buy	$3.50

Show Previous Ratings

Nov-13-23 07:00AM	Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting (GlobeNewswire)
Oct-30-23 12:00PM	Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock Split (GlobeNewswire)
Aug-23-23 12:36PM	Is Catalyst Biosciences (CBIO) Significantly Overvalued? (GuruFocus.com) +11.72%
Apr-03-23 09:01AM	Catalyst Biosciences, Inc. (NASDAQ:CBIO) insiders placed bullish bets worth US$941k in the last 12 months (Simply Wall St.)
Mar-29-23 10:13AM	12 Cheap Healthcare Stocks to Buy in 2023 (Insider Monkey)
08:00AM	Loading…
Feb-28-23 08:00AM	Catalyst Biosciences Provides Corporate Update (GlobeNewswire) +23.75%
Dec-27-22 07:00AM	Catalyst Biosciences Completes First Steps in Reverse Merger Plan (GlobeNewswire)
Nov-16-22 05:05AM	Catalyst Biosciences Third Quarter 2022 Earnings: US$0.15 loss per share (vs US$0.80 loss in 3Q 2021) (Simply Wall St.)
Sep-19-22 09:43AM	Bullish insiders at Catalyst Biosciences, Inc. (NASDAQ:CBIO) loaded up on US$1.2m of stock earlier this year (Simply Wall St.)
Sep-01-22 04:05PM	Catalyst Biosciences, Inc. Announces September 21, 2022 as the Ex-Dividend Date for Special Cash Dividend of $1.43 per share (GlobeNewswire)
Aug-25-22 08:00AM	Catalyst Biosciences, Inc. Declares Special Cash Dividend of $1.43 per share (GlobeNewswire)
Aug-23-22 07:11AM	Catalyst Biosciences (NASDAQ:CBIO) investors are sitting on a loss of 71% if they invested three years ago (Simply Wall St.)
Aug-19-22 08:00AM	Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation (GlobeNewswire)
Aug-15-22 04:05PM	Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results (GlobeNewswire)
Aug-11-22 06:00AM	JDS1, LLC Terminates Proxy Contest at Catalysts 2022 Annual Meeting (Business Wire)
12:46PM	Loading…
Aug-10-22 12:46PM	Catalyst Biosciences Announces Withdrawal of JDS1 Nominations to the Board (GlobeNewswire)
Aug-03-22 08:00AM	Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Catalyst Stockholders Vote FOR All of the Companys Nominees on the WHITE Proxy Card (GlobeNewswire)
Aug-01-22 08:30AM	Catalyst Biosciences Publishes New Investor Presentation (GlobeNewswire)
07:30AM	Catalyst Biosciences Announces Support from Largest Single Stockholder (GlobeNewswire)
Jul-22-22 12:21PM	JDS1, LLC Files Definitive Proxy Statement and Sends Letter to Catalyst Stockholders (Business Wire)
Jul-19-22 08:00AM	Catalyst Biosciences Sends Letter to Stockholders (GlobeNewswire)
Jul-14-22 09:40AM	Has Adicet Bio (ACET) Outpaced Other Medical Stocks This Year? (Zacks)
Jul-06-22 08:00AM	Catalyst Biosciences Comments on Favorable Delaware Court of Chancery Ruling (GlobeNewswire)
Jun-29-22 08:00AM	Catalyst Biosciences Announces Plan to Distribute Cash to Stockholders (GlobeNewswire) +13.25%
Jun-28-22 09:40AM	Has Catalyst Biosciences (CBIO) Outpaced Other Medical Stocks This Year? (Zacks) -5.03%
May-26-22 11:03AM	The Petri Dish: NIH gives $68M to Pfizer-partnered AI startup (American City Business Journals) -22.38%
May-23-22 09:57AM	Catalyst Biosciences Stock More Than Doubles After Assets Sale To Vertex (Benzinga) +234.21%
08:30AM	Catalyst Biosciences Sells Complement Portfolio for $60 Million (GlobeNewswire)
May-09-22 08:30AM	Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results (GlobeNewswire) -11.42%
Apr-08-22 09:57AM	Here's Why Catalyst Biosciences (NASDAQ:CBIO) Must Use Its Cash Wisely (Simply Wall St.) -7.26%
08:00AM	Loading…
Mar-31-22 08:00AM	Catalyst Biosciences Reports Fourth Quarter and Year-end 2021 Operating & Financial Results and Provides a Corporate Update (GlobeNewswire)
Mar-15-22 05:00PM	Catalyst Biosciences Regains Rights to CB 2782-PEG for the Treatment of Dry AMD Expands CBIOs Complement Portfolio in Ophthalmology (GlobeNewswire)
Feb-17-22 08:00AM	Catalyst Biosciences Engages Perella Weinberg Partners to Assist the Company in Exploring Strategic Alternatives (GlobeNewswire) +6.40%
Feb-03-22 05:38PM	Kalos Management, Inc. Buys Vale SA, Sells Consensus Cloud Solutions Inc, Intuitive Surgical ... (GuruFocus.com)
Jan-25-22 08:00AM	Catalyst Biosciences Receives Rare Pediatric Disease Designation for CB 4332 for the Treatment of CFI Deficiency (GlobeNewswire) -7.05%
Jan-12-22 12:00PM	Catalyst Biosciences, Inc. (CBIO) Upgraded to Buy: Here's What You Should Know (Zacks)
Dec-20-21 07:51PM	Penny Stocks to Buy Using Technical Analysis for January 2022 (Investopedia)
Dec-11-21 11:59AM	Timothy P. Lynchs Stonepine Capital Portfolio: Top 10 Healthcare Stocks (Insider Monkey)
Nov-22-21 08:00AM	Catalyst Biosciences to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference (GlobeNewswire)
Nov-12-21 09:54AM	Catalyst Biosciences Down 40% After Announcing MarzAA Development Halt (Investing.com) -41.84%
09:24AM	What Is Happening With Catalyst Biosciences Shares Today? (Benzinga)
07:00AM	Catalyst Biosciences Announces Change in Corporate Strategy (GlobeNewswire)
Oct-29-21 08:00AM	Catalyst Biosciences Announces CFI Variant Presentations at Two Upcoming Scientific Conferences (GlobeNewswire)
Oct-28-21 03:05PM	Catalyst Biosciences, Inc. (CBIO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release (Zacks) +5.03%
Oct-13-21 04:05PM	Catalyst Biosciences Announces Chief Financial Officer Transition (GlobeNewswire)
Sep-28-21 04:01PM	FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency (GlobeNewswire)
Sep-24-21 08:00AM	Catalyst Biosciences to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-17-21 07:06AM	Here's Why We're A Bit Worried About Catalyst Biosciences' (NASDAQ:CBIO) Cash Burn Situation (Simply Wall St.)
Sep-15-21 08:00AM	Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital (GlobeNewswire) +5.64%
Sep-09-21 08:00AM	Catalyst Biosciences Announces Oral and Poster Presentations at the International Conference on Complement Therapeutics (GlobeNewswire)
Sep-08-21 08:00AM	Catalyst Biosciences Announces Appointment of Jeanne Jew to its Board of Directors (GlobeNewswire)
Aug-05-21 10:55AM	Catalyst Biosciences, Inc. (CBIO) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Catalyst Biosciences Reports Second Quarter 2021 Operating & Financial Results and Provides a Corporate Update (GlobeNewswire)
Jul-29-21 03:05PM	Catalyst Biosciences, Inc. (CBIO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
Jul-22-21 08:00AM	Catalyst Biosciences Announces First Patient Screened for CFI deficiency in its CB 4332 Screening and Natural History of Disease Studies (GlobeNewswire)
Jul-19-21 04:01PM	Catalyst Biosciences Presents Four Posters at the International Society for Thrombosis and Haemostasis (ISTH) 2021 Virtual Congress (GlobeNewswire)
02:09AM	Reflecting on Catalyst Biosciences' (NASDAQ:CBIO) Share Price Returns Over The Last Five Years (Simply Wall St.)
Jul-14-21 08:00AM	Catalyst Biosciences Announces Key Leadership Changes in its Ongoing Transition to an Integrated Protease Medicines Company (GlobeNewswire) -6.74%
Jul-06-21 08:00AM	Catalyst Biosciences Announces Presentations at the International Society on Thrombosis and Haemostasis (GlobeNewswire)
Jul-01-21 08:00AM	Catalyst Biosciences to Host Research and Development Day on CB 4332 and Complement Programs (GlobeNewswire)
Jun-28-21 08:45AM	Catalyst Biosciences Stock Moves Higher On Additional FDA Fast Track Tag For MarzAA (Benzinga)
08:00AM	Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Factor VII Deficiency (GlobeNewswire)
Jun-21-21 06:00AM	KBR to Provide Engineering & Technical Services for NATO Allies Patriot System (PR Newswire)
Jun-10-21 08:00AM	Catalyst Biosciences to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
May-20-21 02:57AM	What Type Of Shareholders Own The Most Number of Catalyst Biosciences, Inc. (NASDAQ:CBIO) Shares? (Simply Wall St.)
May-18-21 08:00AM	Catalyst Biosciences Announces First Patient Dosed in Marzeptacog Alfa (Activated) Phase 1/2 Study in Factor VII Deficiency, Glanzmann Thrombasthenia and Hemophilia A treated with Hemlibra (GlobeNewswire)
May-13-21 08:00AM	Catalyst Biosciences to Present at the Truist Securities Life Sciences Summit (GlobeNewswire)
May-06-21 12:19PM	Cigna (CI) to Post Q1 Earnings: Will It Deliver a Beat? (Zacks)
09:23AM	Is a Surprise Coming for Catalyst Biosciences (CBIO) This Earnings Season? (Zacks)
09:15AM	Catalyst Biosciences, Inc. (CBIO) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
08:00AM	Catalyst Biosciences Reports First Quarter 2021 Operating & Financial Results and Provides a Corporate Update (GlobeNewswire)
May-05-21 12:29PM	What's in Store for Select Medical (SEM) Earnings in Q1? (Zacks)
08:00AM	Catalyst Biosciences Announces First Patient Dosed in Pivotal Phase 3 Registration Study of SQ MarzAA in Individuals with Hemophilia A or B with Inhibitors (GlobeNewswire)
Apr-28-21 08:00AM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Catalyst Biosciences, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors (ACCESSWIRE)
Apr-21-21 11:43AM	2 Strong Buy Penny Stocks That Could Deliver Massive Returns (TipRanks) +9.45%
Apr-19-21 08:00AM	Catalyst Biosciences Announces Publication of CB 2679d Preclinical FIX Gene Therapy Data in Blood, the Journal of the American Society of Hematology (GlobeNewswire)
Apr-12-21 08:00AM	Catalyst Biosciences Expands its Protease Medicines Patent Portfolio of Complement Factor 3 Degraders (GlobeNewswire)
Apr-07-21 04:05PM	Catalyst Biosciences to Present at the 20th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-21-21 04:20AM	Will Catalyst Biosciences (NASDAQ:CBIO) Spend Its Cash Wisely? (Simply Wall St.)
Mar-04-21 08:00AM	Catalyst Biosciences Reports Fourth Quarter and Full-Year 2020 Operating & Financial Results and Provides a Corporate Update (GlobeNewswire) -5.91%
Feb-18-21 08:00AM	Catalyst Biosciences to Present at the 42nd Annual Raymond James Institutional Investors Conference (GlobeNewswire) -5.87%
Feb-11-21 04:01PM	Catalyst Biosciences Announces Partial Exercise and Closing of Over-Allotment Option in Public Offering of Common Stock (GlobeNewswire)
Feb-10-21 10:05AM	Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2021 (Benzinga)
Feb-03-21 08:00AM	Catalyst Biosciences Presents Pre-clinical SQ Treatment of Bleeds Data from its Marzeptacog alfa (activated) (MarzAA) Program at the 14th Annual EAHAD Congress (GlobeNewswire)
Jan-29-21 04:01PM	Catalyst Biosciences Announces Closing of Public Offering of Common Stock (GlobeNewswire)
Jan-27-21 08:00AM	Catalyst Biosciences Announces Pricing of Public Offering of Common Stock (GlobeNewswire) -9.16%
Jan-26-21 04:04PM	Catalyst Biosciences Announces Proposed Public Offering of Common Stock (GlobeNewswire) -7.32%
Jan-20-21 08:00AM	Catalyst Biosciences Announces Poster Presentations at the EAHAD 2021 Virtual Congress (GlobeNewswire)
Jan-19-21 11:46PM	If You Had Bought Catalyst Biosciences' (NASDAQ:CBIO) Shares Five Years Ago You Would Be Down 81% (Simply Wall St.)
Jan-15-21 08:00AM	Catalyst Biosciences Participating in a Fireside Chat with LifeSci Capital (GlobeNewswire)
Dec-15-20 10:28PM	Is CBIO A Good Stock To Buy Now? (Insider Monkey)
Dec-07-20 08:00AM	Catalyst Biosciences Presents Crimson 1 Phase 3 Study Design at the 62nd Annual American Society of Hematology Conference (GlobeNewswire)
Dec-03-20 04:02PM	Catalyst Biosciences Hosting Research & Development Call on Systemic Complement Regulator Programs (GlobeNewswire)
08:50AM	Insmed (INSM) Starts Dosing in Phase III Bronchiectasis Study (Zacks)
Dec-02-20 08:00AM	Catalyst Biosciences Receives FDA Fast Track Designation for Subcutaneous MarzAA for the Treatment of Episodic Bleeding in Hemophilia A or B with Inhibitors (GlobeNewswire)
Nov-30-20 10:44AM	Vertex (VRTX) Symkevi/Kalydeco Label Expansion Gets EU Nod (Zacks)
10:42AM	Biogen (BIIB) & Sage Therapeutics Partner for Depression Therapies (Zacks)
Nov-25-20 10:15AM	5 Stocks to Keep an Eye on as Analysts Initiate Coverage (Zacks)
Nov-24-20 04:01PM	Catalyst Biosciences to Present at 32nd Annual Piper Sandler Virtual Healthcare Conference (GlobeNewswire)
Nov-12-20 08:50AM	Zacks.com featured highlights include: Catalyst Biosciences, UFP Industries, VeriSign, InMode and Castle Biosciences (Zacks)

Gyre Therapeutics, Inc. operates as a biopharmaceutical company. It is focused on the development and commercialization of Hydronidone (F351) for the treatment of Metabolic Dysfunction Associated Steatohepatitis (MASH-associated liver fibrosis). The company was founded on March 7, 1997 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GYRE

Gyre Therapeutics Inc

Upgrade your FINVIZ experience